Cargando…

A preliminary study of coronavirus disease 2019 in China: the impact of cardiovascular disease on death risk

INTRODUCTION: The primary purpose of this work is to study coronavirus disease 2019 (COVID-19) in China and to identify the prognostic characteristics of patients with the highest death risk. MATERIAL AND METHODS: The statistical methods used to derive the results of this work are the chi-square tes...

Descripción completa

Detalles Bibliográficos
Autor principal: Rethemiotaki, Irene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717451/
https://www.ncbi.nlm.nih.gov/pubmed/33305058
http://dx.doi.org/10.5114/amsad.2020.98918
_version_ 1783619313324785664
author Rethemiotaki, Irene
author_facet Rethemiotaki, Irene
author_sort Rethemiotaki, Irene
collection PubMed
description INTRODUCTION: The primary purpose of this work is to study coronavirus disease 2019 (COVID-19) in China and to identify the prognostic characteristics of patients with the highest death risk. MATERIAL AND METHODS: The statistical methods used to derive the results of this work are the chi-square test and one-way analysis of variance (ANOVA) to examine the characteristics of COVID-19 associated deaths. A multiple logistic regression analysis was used with the odds ratio (OR) to find statistically significant prognostic factors with the highest death risk for this type of disease. RESULTS: According to multiple logistic regression analyses, males (OR = 1.68; 95% CI: 1.48–1.91) who are over 50 years old (OR = 7.2; 95% CI: 1.01–51.6) from Hubei (OR = 7.73; 95% CI: 5.71–10.47) have the highest risk of death from this type of disease. Moreover, individuals who are retirees (OR = 2.83; 95% CI: 2.47–3.25) and had a Wuhan-related exposure (OR = 2.17; 95% CI: 1.68–2.79) have two times higher risk of death from COVID-19, while the risk is thirteen times higher with the comorbid condition “cardiovascular disease” (OR = 13.6; 95% CI: 10.3–17.9). CONCLUSIONS: The results of this study describe for the first time the importance of cardiovascular disease as a primary prognostic risk factor for death from coronavirus disease 2019.
format Online
Article
Text
id pubmed-7717451
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-77174512020-12-09 A preliminary study of coronavirus disease 2019 in China: the impact of cardiovascular disease on death risk Rethemiotaki, Irene Arch Med Sci Atheroscler Dis Clinical Research INTRODUCTION: The primary purpose of this work is to study coronavirus disease 2019 (COVID-19) in China and to identify the prognostic characteristics of patients with the highest death risk. MATERIAL AND METHODS: The statistical methods used to derive the results of this work are the chi-square test and one-way analysis of variance (ANOVA) to examine the characteristics of COVID-19 associated deaths. A multiple logistic regression analysis was used with the odds ratio (OR) to find statistically significant prognostic factors with the highest death risk for this type of disease. RESULTS: According to multiple logistic regression analyses, males (OR = 1.68; 95% CI: 1.48–1.91) who are over 50 years old (OR = 7.2; 95% CI: 1.01–51.6) from Hubei (OR = 7.73; 95% CI: 5.71–10.47) have the highest risk of death from this type of disease. Moreover, individuals who are retirees (OR = 2.83; 95% CI: 2.47–3.25) and had a Wuhan-related exposure (OR = 2.17; 95% CI: 1.68–2.79) have two times higher risk of death from COVID-19, while the risk is thirteen times higher with the comorbid condition “cardiovascular disease” (OR = 13.6; 95% CI: 10.3–17.9). CONCLUSIONS: The results of this study describe for the first time the importance of cardiovascular disease as a primary prognostic risk factor for death from coronavirus disease 2019. Termedia Publishing House 2020-09-10 /pmc/articles/PMC7717451/ /pubmed/33305058 http://dx.doi.org/10.5114/amsad.2020.98918 Text en Copyright: © 2020 Termedia & Banach http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Clinical Research
Rethemiotaki, Irene
A preliminary study of coronavirus disease 2019 in China: the impact of cardiovascular disease on death risk
title A preliminary study of coronavirus disease 2019 in China: the impact of cardiovascular disease on death risk
title_full A preliminary study of coronavirus disease 2019 in China: the impact of cardiovascular disease on death risk
title_fullStr A preliminary study of coronavirus disease 2019 in China: the impact of cardiovascular disease on death risk
title_full_unstemmed A preliminary study of coronavirus disease 2019 in China: the impact of cardiovascular disease on death risk
title_short A preliminary study of coronavirus disease 2019 in China: the impact of cardiovascular disease on death risk
title_sort preliminary study of coronavirus disease 2019 in china: the impact of cardiovascular disease on death risk
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717451/
https://www.ncbi.nlm.nih.gov/pubmed/33305058
http://dx.doi.org/10.5114/amsad.2020.98918
work_keys_str_mv AT rethemiotakiirene apreliminarystudyofcoronavirusdisease2019inchinatheimpactofcardiovasculardiseaseondeathrisk
AT rethemiotakiirene preliminarystudyofcoronavirusdisease2019inchinatheimpactofcardiovasculardiseaseondeathrisk